FLT3 and acute myeloid leukemia: To exclude the possibility that the potential of PKC412 to reverse MTSS1 downregulation was underestimated due to the high levels of FLT3-ITD in the retrovirally transduced cells, we tested PKC412 in human AML cells carrying a genetic FLT3-ITD mutation (MV4-11).